AVE avecho biotechnology limited

Ann: Appendix 4D and Half-year Financial Report, page-10

  1. 2,993 Posts.
    lightbulb Created with Sketch. 818
    This quarter is over.
    I expect the loss for the quarter to be around $1 million
    cash on hand 3.8 million + 500 000 RD loan

    first patient April
    19 patients finished (1750 inquiries cut to 151.)
    49 being referred end of July (let's say that's another 10 being optimistic)
    29 in a quarter and a month.
    let's say with two more months they are at 40-50.
    by memory and I could be wrong interim analysis need 200
    the timeline for interim analysis starting jan 2025 is very optimistic

    the only caveat is in the last report it said "operating at maximal capacity"
    what does that even mean?
    and last site opened in mid July.

    nice if they had an update
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
-0.001(10.0%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $2.55K 511.1K

Buyers (Bids)

No. Vol. Price($)
26 18250625 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 27692966 23
View Market Depth
Last trade - 12.03pm 25/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.